Functional Electrical Stimulation Market by Product Type, End-Users, and Geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2030

Description

Persistence Market Research has recently published an in-depth analysis of the global Functional Electrical Stimulation Market, offering a comprehensive overview of key market dynamics, growth drivers, challenges, and emerging trends. This report provides valuable insights into the Functional Electrical Stimulation Market, presenting exclusive data and statistics that forecast the market's growth trajectory from 2023 to 2030.

The functional electrical stimulation market is projected to grow at a compound annual growth rate (CAGR) of 4.7%, reaching US$848.8 million by 2030 from US$615.4 million in 2023.

Key Insights:

Functional Electrical Stimulation Market Size (2023E): US$615.4 Million
Projected Market Value (2030F): US$848.8 Million
Global Market Growth Rate (CAGR 2023 to 2030): 4.7%
Historical Market Growth Rate (CAGR 2018 to 2022): 4.1%

Functional Electrical Stimulation Market- Report Scope:

Functional electrical stimulation (FES) utilizes low-energy electrical pulses to induce body movements in individuals with partial or complete paralysis. Initially designed as an assistive device, FES has evolved into a therapeutic technique widely used by clinicians to aid paralysis recovery. Stroke and spinal cord injury are two primary causes of paralysis.

Market growth is fueled by the rising prevalence of musculoskeletal and central nervous system diseases, major contributors to paralysis. According to the World Health Organization (WHO), there are annually 0.25 to 0.5 million new cases of spinal cord injuries, and 1.71 billion individuals suffer from musculoskeletal conditions, including 568 million with lower back-related issues. Additionally, the increasing integration of advanced technology in healthcare is expected to drive market expansion.

Market Growth Drivers:

The global functional electrical stimulation market is expected to grow due to the rising prevalence of central nervous system disorders, leading to partial or complete paralysis. Causes include trauma, degeneration, tumors, stroke, autoimmune diseases, and structural defects. Additionally, musculoskeletal disorders contribute to market expansion, with arthritis, back pain, and trauma being prevalent. FES is increasingly endorsed by medical professionals as part of treatment plans, showing positive outcomes for patients.

Market Restraints:

The use of Functional Electrical Stimulation (FES) in treating paralysis faces certain restraints. Although FES is generally safe when administered by experienced professionals, there are potential risks associated with electrode placement, such as infection, wire breakage, and scar tissue development, particularly with electrodes positioned beneath the skin or in deep tissue. However, externally placed electrodes have not shown adverse effects. Moreover, the high cost of FES treatment poses a significant challenge. With systems ranging from USD 4000 to USD 14000, the overall treatment expenses can be prohibitively expensive, especially in lower-income demographics. This cost disparity may impede widespread adoption unless efforts are made to standardize treatment expenses, ensuring greater accessibility to FES therapy for all individuals in need.

Market Opportunities:

Growing research in Functional Electrical Stimulation (FES) presents significant opportunities for market expansion. With continuous refinement and investment from both private and government entities, there's a strategic focus on enhancing accessibility and affordability, particularly for low-income demographics. This trend underscores promising avenues for substantial growth in the global FES market, offering compelling business opportunities for those looking to capitalize on its expanding presence.

Key Questions Answered in the Report:

What are the key factors driving the growth of the Functional Electrical Stimulation Market?
Which industry verticals are driving the demand for Functional Electrical Stimulation?
How are technological advancements reshaping the competitive landscape of the Functional Electrical Stimulation Market?
Who are the leading players in the global Functional Electrical Stimulation Market?
What are the emerging trends and future prospects in the global Functional Electrical Stimulation Market?

Competitive Intelligence and Business Strategy:

Key players in the Functional Electrical Stimulation (FES) sector, such as Abbott Laboratories, Teva Pharmaceutical Industries Ltd., and Mylan N.V., lead the market with innovative solutions and technological expertise. These companies focus on research and development to introduce new products with improved functionality and user experience. Collaboration and substantial investments are made to fortify their global market positions. To address safety concerns and stand out in the competitive market, they differentiate their products through advanced features, efficacy, and innovative solutions tailored to the needs of patients and healthcare professionals.

Key Companies Profiled:

Abbott Laboratories
Teva Pharmaceutical Industries Ltd.
Mylan N.V.
Sanofi S.A.
GlaxoSmithKline plc
Merck & Co., Inc.
Otsuka Pharmaceutical Co., Ltd.,
Novartis International AG
F. Hoffmann-La Roche AG
Eli Lilly and Company

Functional Electrical Stimulation Market Segmentation:

By Product Type:

Wired
Wireless

By Application:

Neurological Disorders
Orthopedic Disorders
Cardiovascular Disorders
Respiratory Disorders
Others (Urological Disorders, etc.)

By End-User:

Hospitals
Ambulatory Surgical Centres
Clinics

By Region:

North America
Europe
East Asia
South Asia & Oceania
Latin America
Middle East & Africa

Product Code: PMRREP33943

1. Executive Summary

1.1. Global Functional Electrical Stimulation Market Snapshot, 2023 and 2030
1.2. Market Opportunity Assessment, 2023 - 2030, US$ Mn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations

2. Market Overview

2.1. Market Scope and Definition
2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Opportunity
- 2.2.4. Challenges
- 2.2.5. Key Trends
2.3. Product Type Lifecycle Analysis
2.4. Functional Electrical Stimulation Market: Value Chain
- 2.4.1. List of Raw Material Supplier
- 2.4.2. List of Manufacturers
- 2.4.3. List of Distributors
- 2.4.4. List of Applications
- 2.4.5. Profitability Analysis
2.5. Porter Five Force's Analysis
2.6. Geopolitical Tensions: Market Impact
2.7. Macro-Economic Factors
- 2.7.1. Global Sectorial Outlook
- 2.7.2. Global GDP Growth Outlook
- 2.7.3. Global Parent Market Overview
2.8. Forecast Factors - Relevance and Impact
2.9. Regulatory and Technology Landscape

3. Global Functional Electrical Stimulation Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

3.1. Key Highlights
- 3.1.1. Market Volume (Units) Projections
- 3.1.2. Market Size and Y-o-Y Growth
- 3.1.3. Absolute $ Opportunity
3.2. Market Size (US$ Mn) Analysis and Forecast
- 3.2.1. Historical Market Size Analysis, 2013-2016
- 3.2.2. Current Market Size Forecast, 2018-2026
3.3. Global Functional Electrical Stimulation Market Outlook: Product Type
- 3.3.1. Introduction / Key Findings
- 3.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Product Type, 2018 - 2022
- 3.3.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2023 - 2030
  - 3.3.3.1. Wired
  - 3.3.3.2. Wireless
3.4. Market Attractiveness Analysis: Product Type
3.5. Global Functional Electrical Stimulation Market Outlook: Application
- 3.5.1. Introduction / Key Findings
- 3.5.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Application, 2018 - 2022
- 3.5.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
  - 3.5.3.1. Neurological Disorders
  - 3.5.3.2. Orthopedic Disorders
  - 3.5.3.3. Cardiovascular Disorders
  - 3.5.3.4. Respiratory Disorders
  - 3.5.3.5. Others (Urological Disorders, etc.)
3.6. Market Attractiveness Analysis: Application
3.7. Global Functional Electrical Stimulation Market Outlook: End-User
- 3.7.1. Introduction / Key Findings
- 3.7.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By End-User, 2018 - 2022
- 3.7.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By End-User, 2023 - 2030
  - 3.7.3.1. Hospitals
  - 3.7.3.2. AMBULATORY SURGICAL CENTERS
  - 3.7.3.3. CLINICS
3.8. Market Attractiveness Analysis: End-User

4. Global Functional Electrical Stimulation Market Outlook: Region

4.1. Key Highlights
4.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Region, 2018 - 2022
4.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Region, 2023 - 2030
- 4.3.1. North America
- 4.3.2. Europe
- 4.3.3. East Asia
- 4.3.4. South Asia and Oceania
- 4.3.5. Latin America
- 4.3.6. Middle East & Africa (MEA)
4.4. Market Attractiveness Analysis: Region

5. North America Functional Electrical Stimulation Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

5.1. Key Highlights
5.2. Pricing Analysis
5.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
- 5.3.1. By Country
- 5.3.2. By Product Type
- 5.3.3. By Application
- 5.3.4. By End-User
5.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
- 5.4.1. U.S.
- 5.4.2. Canada
5.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2023 - 2030
- 5.5.1. Wired
- 5.5.2. Wireless
5.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
- 5.6.1. Neurological Disorders
- 5.6.2. Orthopedic Disorders
- 5.6.3. Cardiovascular Disorders
- 5.6.4. Respiratory Disorders
- 5.6.5. Others (Urological Disorders, etc.)
5.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End-User, 2023 - 2030
- 5.7.1. Hospitals
- 5.7.2. AMBULATORY SURGICAL CENTERS
- 5.7.3. CLINICS
5.8. Market Attractiveness Analysis

6. Europe Functional Electrical Stimulation Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

6.1. Key Highlights
6.2. Pricing Analysis
6.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
- 6.3.1. By Country
- 6.3.2. By Product Type
- 6.3.3. By Application
- 6.3.4. By End-User
6.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
- 6.4.1. Germany
- 6.4.2. France
- 6.4.3. U.K.
- 6.4.4. Italy
- 6.4.5. Spain
- 6.4.6. Russia
- 6.4.7. T rkiye
- 6.4.8. Rest of Europe
6.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2023 - 2030
- 6.5.1. Wired
- 6.5.2. Wireless
6.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
- 6.6.1. Neurological Disorders
- 6.6.2. Orthopedic Disorders
- 6.6.3. Cardiovascular Disorders
- 6.6.4. Respiratory Disorders
- 6.6.5. Others (Urological Disorders, etc.)
6.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End-User, 2023 - 2030
- 6.7.1. Hospitals
- 6.7.2. AMBULATORY SURGICAL CENTERS
- 6.7.3. CLINICS
6.8. Market Attractiveness Analysis

7. East Asia Functional Electrical Stimulation Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

7.1. Key Highlights
7.2. Pricing Analysis
7.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
- 7.3.1. By Country
- 7.3.2. By Product Type
- 7.3.3. By Application
- 7.3.4. By End-User
7.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
- 7.4.1. China
- 7.4.2. Japan
- 7.4.3. South Korea
7.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2023 - 2030
- 7.5.1. Wired
- 7.5.2. Wireless
7.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
- 7.6.1. Neurological Disorders
- 7.6.2. Orthopedic Disorders
- 7.6.3. Cardiovascular Disorders
- 7.6.4. Respiratory Disorders
- 7.6.5. Others (Urological Disorders, etc.)
7.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End-User, 2023 - 2030
- 7.7.1. Hospitals
- 7.7.2. AMBULATORY SURGICAL CENTERS
- 7.7.3. CLINICS
7.8. Market Attractiveness Analysis

8. South Asia & Oceania Functional Electrical Stimulation Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

8.1. Key Highlights
8.2. Pricing Analysis
8.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
- 8.3.1. By Country
- 8.3.2. By Product Type
- 8.3.3. By Application
- 8.3.4. By End-User
8.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
- 8.4.1. India
- 8.4.2. Southeast Asia
- 8.4.3. ANZ
- 8.4.4. Rest of South Asia & Oceania
8.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2023 - 2030
- 8.5.1. Wired
- 8.5.2. Wireless
8.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
- 8.6.1. Neurological Disorders
- 8.6.2. Orthopedic Disorders
- 8.6.3. Cardiovascular Disorders
- 8.6.4. Respiratory Disorders
- 8.6.5. Others (Urological Disorders, etc.)
8.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End-User, 2023 - 2030
- 8.7.1. Hospitals
- 8.7.2. AMBULATORY SURGICAL CENTERS
- 8.7.3. CLINICS
8.8. Market Attractiveness Analysis

9. Latin America Functional Electrical Stimulation Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

9.1. Key Highlights
9.2. Pricing Analysis
9.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
- 9.3.1. By Country
- 9.3.2. By Product Type
- 9.3.3. By Application
- 9.3.4. By End-User
9.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
- 9.4.1. Brazil
- 9.4.2. Mexico
- 9.4.3. Rest of Latin America
9.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2023 - 2030
- 9.5.1. Wired
- 9.5.2. Wireless
9.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
- 9.6.1. Neurological Disorders
- 9.6.2. Orthopedic Disorders
- 9.6.3. Cardiovascular Disorders
- 9.6.4. Respiratory Disorders
- 9.6.5. Others (Urological Disorders, etc.)
9.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End-User, 2023 - 2030
- 9.7.1. Hospitals
- 9.7.2. AMBULATORY SURGICAL CENTERS
- 9.7.3. CLINICS
9.8. Market Attractiveness Analysis

10. Middle East & Africa Functional Electrical Stimulation Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

10.1. Key Highlights
10.2. Pricing Analysis
10.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
- 10.3.1. By Country
- 10.3.2. By Product Type
- 10.3.3. By Application
- 10.3.4. By End-User
10.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
- 10.4.1. GCC
- 10.4.2. Egypt
- 10.4.3. South Africa
- 10.4.4. Northern Africa
- 10.4.5. Rest of Middle East & Africa
10.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product Type, 2023 - 2030
- 10.5.1. Wired
- 10.5.2. Wireless
10.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
- 10.6.1. Neurological Disorders
- 10.6.2. Orthopedic Disorders
- 10.6.3. Cardiovascular Disorders
- 10.6.4. Respiratory Disorders
- 10.6.5. Others (Urological Disorders, etc.)
10.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By End-User, 2023 - 2030
- 10.7.1. Hospitals
- 10.7.2. AMBULATORY SURGICAL CENTERS
- 10.7.3. CLINICS
10.8. Market Attractiveness Analysis

11. Competition Landscape

11.1. Market Share Analysis, 2022
11.2. Market Structure
- 11.2.1. Competition Intensity Mapping By Market
- 11.2.2. Competition Wireless
- 11.2.3. Apparent Product Capacity
11.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
- 11.3.1. Abbott Laboratories
  - 11.3.1.1. Overview
  - 11.3.1.2. Segments and Product
  - 11.3.1.3. Key Financials
  - 11.3.1.4. Market Developments
  - 11.3.1.5. Market Strategy
- 11.3.2. Teva Pharmaceutical Industries Ltd.
  - 11.3.2.1. Overview
  - 11.3.2.2. Segments and Product
  - 11.3.2.3. Key Financials
  - 11.3.2.4. Market Developments
  - 11.3.2.5. Market Strategy
- 11.3.3. Mylan N.V.
  - 11.3.3.1. Overview
  - 11.3.3.2. Segments and Product
  - 11.3.3.3. Key Financials
  - 11.3.3.4. Market Developments
  - 11.3.3.5. Market Strategy
- 11.3.4. Sanofi S.A.
  - 11.3.4.1. Overview
  - 11.3.4.2. Segments and Product
  - 11.3.4.3. Key Financials
  - 11.3.4.4. Market Developments
  - 11.3.4.5. Market Strategy
- 11.3.5. GlaxoSmithKline plc
  - 11.3.5.1. Overview
  - 11.3.5.2. Segments and Product
  - 11.3.5.3. Key Financials
  - 11.3.5.4. Market Developments
  - 11.3.5.5. Market Strategy
- 11.3.6. Merck & Co., Inc.
  - 11.3.6.1. Overview
  - 11.3.6.2. Segments and Product
  - 11.3.6.3. Key Financials
  - 11.3.6.4. Market Developments
  - 11.3.6.5. Market Strategy
- 11.3.7. Otsuka Pharmaceutical Co., Ltd.,
  - 11.3.7.1. Overview
  - 11.3.7.2. Segments and Product
  - 11.3.7.3. Key Financials
  - 11.3.7.4. Market Developments
  - 11.3.7.5. Market Strategy
- 11.3.8. Novartis International AG
  - 11.3.8.1. Overview
  - 11.3.8.2. Segments and Product
  - 11.3.8.3. Key Financials
  - 11.3.8.4. Market Developments
  - 11.3.8.5. Market Strategy
- 11.3.9. F. Hoffmann-La Roche AG
  - 11.3.9.1. Overview
  - 11.3.9.2. Segments and Product
  - 11.3.9.3. Key Financials
  - 11.3.9.4. Market Developments
  - 11.3.9.5. Market Strategy
- 11.3.10. Eli Lilly and Company
  - 11.3.10.1. Overview
  - 11.3.10.2. Segments and Product
  - 11.3.10.3. Key Financials
  - 11.3.10.4. Market Developments
  - 11.3.10.5. Market Strategy

12. Appendix

12.1. Research Methodology
12.2. Research Assumptions
12.3. Acronyms and Abbreviations